Back to Market Feed

Product Information

TIOTROPIUM 18 MCG CAP-INHALER is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $11.7122 per EA under NDC 68180096412. Its NADAC has been published 149 times since Oct 18, 2023.

FDA first approved this application on Jun 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TIOTROPIUM 18 MCG CAP-INHALER

Tiotropium Bromide
$11.7122per EA

Strength

18 ug/1

NDC

68180096412

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL; RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211287

FDA Approved

6/20/2023

TE Code

AB

On Market Since

8/16/2023

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price Statistics

The NADAC for TIOTROPIUM 18 MCG CAP-INHALER has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.

Current price$11.7122 per EA
All-time high$13.9717 (Jan 10, 2024)
All-time low$11.2708 (Jul 17, 2024)
52-week high$12.6614
52-week low$11.4807
Median price$12.3469
Average price$12.4880
Largest weekly change+17.7% (Jun 19, 2024)
Weeks tracked149
Tracking sinceOct 18, 2023

Price History

1W

+2.0%

1M

+2.0%

3M

-1.3%

6M

-0.8%

1Y

-7.5%

3Y

N/A

5Y

N/A

All

-15.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tiotropium Bromide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

IPRATROPIUM BR 0.02% SOLN
Generic
00487980102•Nephron Pharmaceuticals Corporation
$0.0529
per ML
DICYCLOMINE 20 MG TABLET
Generic
00832605210•Upsher-Smith Laboratories LLC
$0.0563
per EA
DICYCLOMINE 20 MG TABLET
Generic
00143122701•Hikma Pharmaceuticals USA Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00143122710•Hikma Pharmaceuticals USA Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128201•Lannett Company Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128210•Lannett Company Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079501•Actavis Pharma, Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079510•Actavis Pharma, Inc.
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00832605211•Upsher-Smith Laboratories LLC
$0.0587
per EA
DICYCLOMINE 20 MG TABLET
Generic
00904698861•Major Pharmaceuticals
$0.0587
per EA

Frequently asked questions

What is the NADAC price of TIOTROPIUM 18 MCG CAP-INHALER?

The current National Average Drug Acquisition Cost (NADAC) for TIOTROPIUM 18 MCG CAP-INHALER, manufactured by Lupin Pharmaceuticals Inc., is $11.7122 per EA (NDC 68180096412), effective Aug 19, 2026.

How has the price of TIOTROPIUM 18 MCG CAP-INHALER changed over time?

Over the history we have for it, the NADAC for TIOTROPIUM 18 MCG CAP-INHALER has declined 15.6%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for TIOTROPIUM 18 MCG CAP-INHALER?

Since Oct 18, 2023, the NADAC for TIOTROPIUM 18 MCG CAP-INHALER has ranged from a low of $11.2708 (Jul 17, 2024) to a high of $13.9717 (Jan 10, 2024), with a median of $12.3469 per EA.

Are there cheaper alternatives to TIOTROPIUM 18 MCG CAP-INHALER?

No other NADAC-published product currently shares the active ingredient and strength of TIOTROPIUM 18 MCG CAP-INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TIOTROPIUM 18 MCG CAP-INHALER?

TIOTROPIUM 18 MCG CAP-INHALER (NDC 68180096412) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.